[Double-blind clinical trial of a new anti-hemorrhagic drug].
D002986:Clinical Trials as Topic; D003029:Coagulants / Q000627:therapeutic use*; D004311:Double-Blind Method; D005169:Factor VIII / Q000627:therapeutic use*; D005260:Female; D006417:Hematuria / Q000188:drug therapy*; D006801:Humans; D036341:Intercellular Signaling Peptides and Proteins; D008297:Male; D010455:Peptides / Q000627:therapeutic use*; D011897:Random Allocation
D003029:Coagulants; D036341:Intercellular Signaling Peptides and Proteins; D010455:Peptides; C021266:vascular factor; D005169:Factor VIII
Sperimentazione clinica a doppio cieco su un nuovo farmaco ad azione antiemorragica.